America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Making money in a week is achievable with effective strategies. Explore various options to earn cash quickly.
16,701 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A new survey of 351 institutions finds 25% intend to add XRP in 2026, joining the 18% already holding the token. Pric...
Hidden vesting schedules and missing year-end true-ups can erase thousands in employer matching. Workers must read pl...
Ethereum presses against a $2,400 resistance as institutional buyers accumulate and BitMine builds a sizable ETH stak...
As pharmacy discounts proliferate, insured customers may chase lower prices at the counter only to discover long-term...
Two popular ETFs both target consumer staples, but their weighting methods lead to distinct risk and return profiles....
Embecta faced a sharp decline after its quarterly report, leaving investors wondering about the near-term outlook. Th...
Bitcoin faces a pivotal crossroad as the 4-year cycle motif intersects ETF-driven demand and the lingering effects of...
A rare can shortage is turning a familiar cola into a symbol of status in India’s urban youth. This story examines ho...
DraftKings reports a mixed Q1 2026 while signaling growth hinges on prediction markets and regulatory clarity. A path...
Alphabet and Meta Platforms sit at the center of digital advertising and AI bets. This analysis breaks down which cou...
New data from Northwestern Mutual reveals Gen X is running out of time to fund retirement, with a majority unsure abo...